Katie Ewer
Katie Ewer, an Associate Professor at The Jenner Institute, University of Oxford, focuses on infectious diseases with a keen interest in vaccine development against endemic diseases like malaria and outbreak pathogens such as Ebola virus.
Her group at The Jenner Institute is actively involved in the development of malaria vaccines, including R21, ChAd63 ME-TRAP, and MVA ME-TRAP, currently undergoing Phase I and II clinical trials in the UK, Burkina Faso, and Kenya.
Katie Ewer's research aims to identify vaccine-induced immunological markers associated with protection from malaria. Her work involves extensive analysis of immune responses through various techniques like ELISPOT, flow cytometry, and transcriptional profiling for T cells, as well as detailed evaluation of antibody responses.
In addition to malaria, Ewer's team at The Jenner Institute is also dedicated to creating vaccines against emerging and outbreak pathogens like Ebola, MERS, influenza, Lassa, and Nipah, conducting comprehensive immunophenotyping of vaccine-induced T cell and antibody responses in clinical trial samples.
Her academic journey includes a BSc (Hons) in Biomedical Science from De Montfort University, a PhD in TB Immunology from The Open University, and previous roles as a Post Doc at Veterinary Laboratories Agency, Translational Research Scientist at Animal Health and Veterinary Laboratories Agency, and Research Assistant at University of Oxford.
Katie Ewer's research work is vital in advancing the understanding of immune responses to infection and vaccination, with the ultimate goal of improving public health outcomes through innovative vaccine development efforts.
